Celerion Sites Gains Brazil Approval

Celerion’s clinical research operations in Belfast, Northern Ireland, and its clinical research and bioanalytical services operations in Lincoln, NE, have been certified by the Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária – ANVISA). ANVISA provides regulatory approval for drugs and other products seeking to enter the Brazilian market.

“The approval of ANVISA continues to demonstrate the high quality work done at Celerion,” said Susan Thornton, president and chief executive officer. “By earning ANVISA certification to conduct early clinical studies and bioanalytical research for compounds destined for Brazil, Celerion is now able to better serve our clients’ growing needs in this high–growth, emerging market.”

Additionally, Celerion’s Belfast facility has been certified by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). The facility has received both Standard and Supplementary Accreditation, which certifies that the general standards for study participant safety and access to emergency medical response have been met.